表紙:感染症サーベイランスソリューションの世界市場 - タイプ、用途、地域別 - 成長、トレンド、および予測
市場調査レポート
商品コード
645345

感染症サーベイランスソリューションの世界市場 - タイプ、用途、地域別 - 成長、トレンド、および予測

Infection Surveillance Solutions Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
感染症サーベイランスソリューションの世界市場 - タイプ、用途、地域別 - 成長、トレンド、および予測
出版日: 2021年01月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の感染症サーベイランスソリューション市場は、2018年から2023年にかけて、12.50%のCAGRで拡大すると予測されています。

当レポートでは、感染症サーベイランスソリューションの世界市場を調査し、市場の概要、タイプ、エンドユーザー、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 市場の定義
  • 調査の前提条件

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場の分析

  • 市場概況
  • 業界の魅力 - ファイブフォース分析
    • 新規参入の脅威
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 代替製品の脅威
    • 業界内での競争
  • バリューチェーン分析
  • 産業政策

第5章 市場のダイナミクス

  • 市場の成長要因
  • 市場の阻害要因

第6章 技術概要

第7章 市場セグメンテーション

  • 製品別
    • ソフトウェア
    • サービス
  • エンドユーザー別
    • 病院
    • 長期ケア施設
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中南米
    • 中東・アフリカ

第8章 市場シェア分析

第9章 企業プロファイル

  • Becton, Dickinson and Company
  • Premier Inc.
  • DEB Group Ltd.
  • RL Solutions
  • Hygreen Inc.
  • Baxter International Inc.
  • Atlas Medical Software
  • Gojo Industries Inc.
  • ICNet International Limited
  • Wolters Kluwer NV
  • Truven Health Analytics

第10章 投資分析

第11章 市場の将来展望

目次
Product Code: 50819

The Infection Surveillance Solutions market was valued at USD 372.18 million in 2020 and is expected to reach USD 712.27 million by 2026, at a CAGR of 12.50% over the forecast period (2021 - 2026). Hospital-associated infections in a clinical setting, such as surgical site infections, urinary tract infection, etc., have prompted healthcare professionals to adopt infection surveillance systems to identify possible healthcare-associated infections in the duration of patient stay in hospitals.

  • Lack of sanitation, non-adherence to prescribed medication and increasing trend of self-medication has resulted in antibiotic resistance by bacteria. There is an urgent requirement of a surveillance system to keep in check the proliferation of hospital-acquired infection and mortality associated with dreadful diseases, such as pneumonia, tuberculosis, Ebola, malaria, etc.
  • Moreover, increased capacity of IT systems to perform analytic processing, coupled with technological advancements in IT systems, is aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. These solutions include the usage of algorithms with electronic medical records, specialized data mining software, and fully automated HAI surveillance by employing clinical support based knowledge that helps in the identification of certain clinical terms.
  • However, the high cost of the software and dearth of proper knowledge, impede market growth during the forecasted period.

Key Market Trends

Initiative to Curb Health Care-associated Infection to Drive the Market Growth

  • The healthcare-associated infections (HAIs) are infections that patients get while receiving treatment for medical or surgical conditions, and many HAIs are preventable. Common types of HAIs include catheter-associated urinary tract infections, surgical site infections, pneumonia, influenza, etc.
  • Therefore, hospitals and other healthcare centers are turning to software analytical tools for solutions. Infection surveillance analytics help organize and interpret health data by investigating the various parameters, and incorporation those for the implementation and estimation of public health practice to control the frequency of associated healthcare infections.
  • Such extent of usability of the solutions and enabling the next level of the healthcare ecosystem is expected to remain a significant driver to prompt the governments to adopt such solutions. Moreover, the National Action Plan to Prevent Health Care-Associated Infections was released by the United States to eliminate the HAIs. It includes a chapter on increasing influenza and pneumonia. coverage of health care personnel. Additionally, organizations like NIH is increasing its funding to curb the common HAIs, such as influenza and pneumonia. Thus, to support this initiative, infection surveillance solutions will be very useful.
  • Therefore, the above factors are providing the impetus to the vendors in the market to extend the reach in the new market.

North America to Dominate the Market

  • North America is one of the largest markets for medical technology research industries, globally. The huge market in the region is mainly due to growing R&D activities in the medical sciences. Particularly in the United States of America Health and Human Services (HHS), which is governed by the cabinet-level department of the US federal government is very liberal in funding and maintaining the technological research in medical sciences.
  • Studies also stated that in the United States, 1 out of every 25 hospitalized patients suffers from HAI. As many of these infections occur in the intensive care unit (ICU), hospitals are facing struggles in reducing the infection rate. Due to these issues, the US Department of Health and Human Services made it a priority and made it as a national reduction of HAIs with the objective of building a safer, more inexpensive healthcare system, for all Americans.
  • Moreover, in the United States, increasing healthcare costs are prompting the individual hospitals to move, or merge with independent healthcare groups to form larger healthcare systems that can broaden their service reach, leverage economies of scale, and also can withstand rising regulatory pressures from the recent government.
  • These dynamics are influencing the growth of the technological advances in the hospital, which in turn, boost the infection surveillance solutions market.

Competitive Landscape

The infection surveillance solutions market is competitive in nature due to the presence of many major players. Some of the players are Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, etc.

  • May 2019 - RL Solutions acquired iContracts. Involved in the contract was policy, and revenue management, along with the iContracts' comprehensive suite of cloud-based solutions, helping the healthcare firms to manage risk and compliance, and also life sciences organizations to navigate complex revenue management processes.
  • July 2018 - RL Solutions and Datix Limited, prominent players in healthcare quality and patient safety software, collaborated to form a global leader in patient safety, quality, and infection prevention.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Stringent Government Policies for Preventing Hospital Associated Infections
    • 4.2.2 Rise in the Number of Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools
  • 4.4 Industry Value Chain Analysis
  • 4.5 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 TECHNOLOGY SNAPSHOT AND INDUSTRY POLICY

6 MARKET SEGMENTATION

  • 6.1 By Offering
    • 6.1.1 Software
      • 6.1.1.1 On-Premise
      • 6.1.1.2 Cloud
    • 6.1.2 Service
      • 6.1.2.1 Maintenance and Support
      • 6.1.2.2 Consultation and Training
      • 6.1.2.3 Implementation Service
  • 6.2 By End User
    • 6.2.1 Hospitals
    • 6.2.2 Long-term Care Facilities
    • 6.2.3 Other End Users
  • 6.3 Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 France
      • 6.3.2.4 Italy
      • 6.3.2.5 Spain
      • 6.3.2.6 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
      • 6.3.3.4 Rest of Asia-Pacific
    • 6.3.4 Rest of the World
      • 6.3.4.1 Latin America
      • 6.3.4.2 Middle-East & Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Cerner Corporation
    • 7.1.2 Epic Systems Corporation
    • 7.1.3 VigiLanz Corporation
    • 7.1.4 Becton, Dickinson and Company
    • 7.1.5 Premier Inc.
    • 7.1.6 DEB Group Ltd
    • 7.1.7 RL Solutions
    • 7.1.8 Baxter International Inc. (ICNet International)
    • 7.1.9 Gojo Industries Inc.
    • 7.1.10 IBM Corporation (Truven Health Analytics)

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS